- call +1-201-465-4211
- email sales@mrinsights.biz
Parry–Romberg syndrome, also known as progressive hemifacial atrophy, is a rare disease characterized by progressive shrinkage and degeneration of the tissues beneath the skin, usually on only one side of the face (hemifacial atrophy) but occasionally extending to other parts of the body. An autoimmune mechanism is suspected, and the syndrome may be a variant of localized scleroderma, but the precise cause and pathogenesis of this acquired disorder remains unknown.
Scope of the Report:
This report studies the Parry-Romberg Syndrome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parry-Romberg Syndrome market by product type and applications/end industries.
Medical management may involve immunosuppressive drugs such as methotrexate, corticosteroids, cyclophosphamide, and azathioprine. No randomized controlled trials have yet been conducted to evaluate such treatments, so the benefits have not been clearly established. Affected individuals may benefit from autologous fat transfer or fat grafts to restore a more normal contour to the face. However, greater volume defects may require microsurgical reconstructive surgerywhich may involve the transfer of an island parascapular fasciocutaneous flap or a free flap from the groin, rectus abdominis muscle (Transverse Rectus Abdominis Myocutaneous or "TRAM" flap) or latissimus dorsi muscle to the face.
The global Parry-Romberg Syndrome market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parry-Romberg Syndrome.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
DePuy Synthes
Johnson & Johnson Services
Medtronic
Abbott
Immediate Media Company
Taj Pharmaceuticals
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Medical Examination
MRI Scan
Serum Test
Market Segment by Applications, can be divided into
Hospital & Clinics
Physical Therapists
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Parry-Romberg Syndrome Market Overview
1.1 Product Overview and Scope of Parry-Romberg Syndrome
1.2 Classification of Parry-Romberg Syndrome by Types
1.2.1 Global Parry-Romberg Syndrome Revenue Comparison by Types (2017-2023)
1.2.2 Global Parry-Romberg Syndrome Revenue Market Share by Types in 2017
1.2.3 Medical Examination
1.2.4 MRI Scan
1.2.5 Serum Test
1.3 Global Parry-Romberg Syndrome Market by Application
1.3.1 Global Parry-Romberg Syndrome Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital & Clinics
1.3.3 Physical Therapists
1.4 Global Parry-Romberg Syndrome Market by Regions
1.4.1 Global Parry-Romberg Syndrome Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Parry-Romberg Syndrome Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parry-Romberg Syndrome Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parry-Romberg Syndrome Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Parry-Romberg Syndrome Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parry-Romberg Syndrome Status and Prospect (2013-2023)
1.5 Global Market Size of Parry-Romberg Syndrome (2013-2023)
2 Manufacturers Profiles
2.1 DePuy Synthes
2.1.1 Business Overview
2.1.2 Parry-Romberg Syndrome Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 DePuy Synthes Parry-Romberg Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson Services
2.2.1 Business Overview
2.2.2 Parry-Romberg Syndrome Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Services Parry-Romberg Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medtronic
2.3.1 Business Overview
2.3.2 Parry-Romberg Syndrome Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Parry-Romberg Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott
2.4.1 Business Overview
2.4.2 Parry-Romberg Syndrome Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Parry-Romberg Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.5 Immediate Media Company
2.5.1 Business Overview
2.5.2 Parry-Romberg Syndrome Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Immediate Media Company Parry-Romberg Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.6 Taj Pharmaceuticals
2.6.1 Business Overview
2.6.2 Parry-Romberg Syndrome Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Taj Pharmaceuticals Parry-Romberg Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Parry-Romberg Syndrome Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Parry-Romberg Syndrome Revenue, Gross Margin and Market Share (2016-2017)
3 Global Parry-Romberg Syndrome Market Competition, by Players
3.1 Global Parry-Romberg Syndrome Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Parry-Romberg Syndrome Players Market Share
3.2.2 Top 10 Parry-Romberg Syndrome Players Market Share
3.3 Market Competition Trend
4 Global Parry-Romberg Syndrome Market Size by Regions
4.1 Global Parry-Romberg Syndrome Revenue and Market Share by Regions
4.2 North America Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
4.3 Europe Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
4.5 South America Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
5 North America Parry-Romberg Syndrome Revenue by Countries
5.1 North America Parry-Romberg Syndrome Revenue by Countries (2013-2018)
5.2 USA Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
5.3 Canada Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
5.4 Mexico Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
6 Europe Parry-Romberg Syndrome Revenue by Countries
6.1 Europe Parry-Romberg Syndrome Revenue by Countries (2013-2018)
6.2 Germany Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
6.3 UK Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
6.4 France Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
6.5 Russia Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
6.6 Italy Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Parry-Romberg Syndrome Revenue by Countries
7.1 Asia-Pacific Parry-Romberg Syndrome Revenue by Countries (2013-2018)
7.2 China Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
7.3 Japan Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
7.4 Korea Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
7.5 India Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
8 South America Parry-Romberg Syndrome Revenue by Countries
8.1 South America Parry-Romberg Syndrome Revenue by Countries (2013-2018)
8.2 Brazil Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
8.3 Argentina Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
8.4 Colombia Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Parry-Romberg Syndrome by Countries
9.1 Middle East and Africa Parry-Romberg Syndrome Revenue by Countries (2013-2018)
9.2 Saudi Arabia Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
9.3 UAE Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
9.4 Egypt Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
9.5 Nigeria Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
9.6 South Africa Parry-Romberg Syndrome Revenue and Growth Rate (2013-2018)
10 Global Parry-Romberg Syndrome Market Segment by Type
10.1 Global Parry-Romberg Syndrome Revenue and Market Share by Type (2013-2018)
10.2 Global Parry-Romberg Syndrome Market Forecast by Type (2018-2023)
10.3 Medical Examination Revenue Growth Rate (2013-2023)
10.4 MRI Scan Revenue Growth Rate (2013-2023)
10.5 Serum Test Revenue Growth Rate (2013-2023)
11 Global Parry-Romberg Syndrome Market Segment by Application
11.1 Global Parry-Romberg Syndrome Revenue Market Share by Application (2013-2018)
11.2 Parry-Romberg Syndrome Market Forecast by Application (2018-2023)
11.3 Hospital & Clinics Revenue Growth (2013-2018)
11.4 Physical Therapists Revenue Growth (2013-2018)
12 Global Parry-Romberg Syndrome Market Size Forecast (2018-2023)
12.1 Global Parry-Romberg Syndrome Market Size Forecast (2018-2023)
12.2 Global Parry-Romberg Syndrome Market Forecast by Regions (2018-2023)
12.3 North America Parry-Romberg Syndrome Revenue Market Forecast (2018-2023)
12.4 Europe Parry-Romberg Syndrome Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Parry-Romberg Syndrome Revenue Market Forecast (2018-2023)
12.6 South America Parry-Romberg Syndrome Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Parry-Romberg Syndrome Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Parry-Romberg Syndrome Picture
Table Product Specifications of Parry-Romberg Syndrome
Table Global Parry-Romberg Syndrome and Revenue (Million USD) Market Split by P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
